Gut microbiota, the pharmabiotics they produce and host health

  title={Gut microbiota, the pharmabiotics they produce and host health},
  author={Elaine Patterson and John F. Cryan and Gerald F. Fitzgerald and Reynolds Paul Ross and Timothy G. Dinan and Catherine Stanton},
  journal={Proceedings of the Nutrition Society},
  pages={477 - 489}
A healthy gut microbiota plays many crucial functions in the host, being involved in the correct development and functioning of the immune system, assisting in the digestion of certain foods and in the production of health-beneficial bioactive metabolites or ‘pharmabiotics’. These include bioactive lipids (including SCFA and conjugated linoleic acid) antimicrobials and exopolysaccharides in addition to nutrients, including vitamins B and K. Alterations in the composition of the gut microbiota… 
Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates
All animals develop in association with complex microbial communities. It is now well established that commensal microbiota is essential for the correct functionality of each organ in the host.
Beneficial Microbes: The pharmacy in the gut
Prebiotics are selectively fermented ingredients that allow specific changes, both in the composition and/or activity in the gastrointestinal microflora, which confers benefits upon host well-being and health.
Gut microbiota, obesity and diabetes
This review will investigate the intricate axis between the microbiota and host metabolism, while also addressing the promising and novel field of probiotics as metabolic therapies.
Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
Interactions between circulating gut-derived microbial metabolites, and the blood–brain barrier (BBB) also contribute to the gut-brain axis, representing a fourth facet of the gut–brain axis that warrants further attention.
Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions
This review aims to integrate the contribution of the gut microbiome in health and disease to xenobiotic metabolism focusing on therapeutic interventions, pharmacological drug action, and chemical biotransformations that collectively will have implications for the future practice of precision medicine.
Probiotics in human health and disease: from nutribiotics to pharmabiotics
Probiotics are reviewed as nutribiotics with nutritional functions and pharmabiotics with pharmaceutic functions in different diseases, describing the current understanding in the conceptualization and classification of probiotics.
Probiotics and Prebiotics
This chapter discusses the effects of probiotics on GIT ecology, and deals with the appropriateness, technological suitability, competitiveness, and performance and functionality, as the criteria for selection of probiotic cultures.
Microbial–host metabolic systems interactions and the gut–brain axis: protective effects of microbial propionate upon the blood–brain barrier
Interactions between circulating gut-derived microbial metabolites and the blood–brain barrier (BBB) also contribute to the gut–brain axis, representing a fourth facet of the gut-brain axis that warrants further attention.
Microbiota regulation of the Mammalian gut-brain axis.
Harnessing Gut Microbes for Mental Health: Getting From Here to There


Probiotics, Prebiotics, and Synbiotics: Gut and Beyond
Genomics and bioinformatics tools may allow us to establish mechanistic relationships among gut microbiota, health status, and the effects of drugs in the individual, and will hopefully provide perspectives for personalized gut microbiota management.
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
The manipulation of the gut microbiota is considered as a potential therapeutic option to treat chronic gastrointestinal disease and recently developed genomic and other tools used to study the gut microbiome are highlighted.
The microbiome‐gut‐brain axis: from bowel to behavior
  • J. Cryan, S. O'Mahony
  • Biology, Medicine
    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2011
It is shown that germ‐free mice display alterations in stress‐responsivity, central neurochemistry and behavior indicative of a reduction in anxiety in comparison to conventional mice, offering the enticing proposition that specific modulation of the enteric microbiota may be a useful strategy for stress‐related disorders and for modulating the co‐morbid aspects of gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease.
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era.
The specialty of gastroenterology will be affected profoundly by the ability to modify the gastrointestinal microbiota through the rational deployment of antibiotics, probiotics, and prebiotics.
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
The emerging concept of a microbiota–gut–brain axis suggests that modulation of the gut microbiota may be a tractable strategy for developing novel therapeutics for complex CNS disorders.
An update on the use and investigation of probiotics in health and disease
Progress in this area will be facilitated by optimising strain, dose and product formulations, including protective commensal species; matching these formulations with selectively responsive subpopulations; and identifying ways to manipulate diet to modify bacterial profiles and metabolism.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
It is shown that SCFA–GPR43 interactions profoundly affect inflammatory responses, and GPR43 binding of SCFAs potentially provides a molecular link between diet, gastrointestinal bacterial metabolism, and immune and inflammatory responses.
The gut microbiota shapes intestinal immune responses during health and disease
Findings indicating that developmental aspects of the adaptive immune system are influenced by bacterial colonization of the gut are discussed, and the possibility that the mammalian immune system, which seems to be designed to control microorganisms, is in fact controlled by microorganisms is raised.
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
This review summarizes the role of SCFAs in host energy metabolism, starting from the production by the gut microbiota to the uptake by the host and ending with the effects on host metabolism.